Skip Navigation

Neuro-Oncology 2009 11(1):9-21; doi:10.1215/15228517-2008-081
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Li, L.
Right arrow Articles by Ross, A. H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Li, L.
Right arrow Articles by Ross, A. H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright 2009 by the Society for Neuro-Oncology

EGFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors

Li Li, Amalia Dutra, Evgenia Pak, Joseph E. Labrie, III, Rachel M. Gerstein, Pier Paolo Pandolfi, Larry D. Recht and Alonzo H. Ross

Departments of Biochemistry and Molecular Pharmacology (L.L., A.H.R.) and Molecular Genetics and Microbiology (J.E.L., R.M.G.), University of Massachusetts Medical School, Worcester, MA; National Human Genome Research Institute, National Institutes of Health, Bethesda, MD (A.D., E.P.); Program of Cancer Genetics, Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA (P.P.P.); Department of Neurology and Neurological Sciences, Stanford University Medical School, Palo Alto, CA (L.D.R.); USA

Address correspondence to Alonzo H. Ross, Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, 364 Plantation St., Worcester, MA 01605, USA (Alonzo.Ross{at}umassmed.edu).


   Abstract

Glioblastomas often show activation of epidermal growth factor receptor (EGFR) and loss of PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor, but it is not known if these two genetic lesions act together to transform cells. To answer this question, we infected PTEN–/– neural precursor cells with a retrovirus encoding EGFRvIII, which is a constitutively activated receptor. EGFRvIII PTEN–/– cells formed highly mitotic tumors with nuclear pleomorphism, necrotic areas, and glioblastoma markers. The transformed cells showed increased cell proliferation, centrosome amplification, colony formation in soft agar, self-renewal, expression of the stem cell marker CD133, and resistance to oxidative stress and ionizing radiation. The RAS/mitogen-activated protein kinase (ERK) and phosphoinositide 3-kinase/protein kinase B (PI3K/Akt) pathways were activated, and checkpoint kinase 1 (Chk1), the DNA damage regulator, was phosphorylated at S280 by Akt, suppressing Chk1 phosphorylation at S345 in response to ionizing irradiation. The PTEN–/– cells showed low levels of DNA damage in the absence of irradiation, which was increased by EGFRvIII expression. Finally, secondary changes occurred during tumor growth in mice. Cells from these tumors showed decreased tumor latencies and additional chromosomal aberrations. Most of these tumor lines showed translocations of mouse chromosome 15. Intracranial injections of one of these lines led to invasive, glial fibrillary acidic protein–positive, nestin-positive tumors. These results provide a molecular basis for the occurrence of these two genetic lesions in brain tumors and point to a role in induction of genomic instability.

Keywords: aneuploidy, EGFRvIII, glioblastoma, neural precursor cells, PTEN

Received December 10, 2007; Accepted April 29, 2008


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Z. Li, H. Wang, C. E. Eyler, A. B. Hjelmeland, and J. N. Rich
Turning Cancer Stem Cells Inside Out: An Exploration of Glioma Stem Cell Signaling Pathways
J. Biol. Chem., June 19, 2009; 284(25): 16705 - 16709.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.